Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

Bibliographic Details
Main Authors: Jose W. Ricardo, MD, Shari R. Lipner, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512621006433
_version_ 1819020506803732480
author Jose W. Ricardo, MD
Shari R. Lipner, MD, PhD
author_facet Jose W. Ricardo, MD
Shari R. Lipner, MD, PhD
author_sort Jose W. Ricardo, MD
collection DOAJ
first_indexed 2024-12-21T03:52:18Z
format Article
id doaj.art-fa6f34f66f3a4b9699aadca29a9062f7
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-12-21T03:52:18Z
publishDate 2021-11-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-fa6f34f66f3a4b9699aadca29a9062f72022-12-21T19:16:57ZengElsevierJAAD Case Reports2352-51262021-11-01171820Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccineJose W. Ricardo, MD0Shari R. Lipner, MD, PhD1Department of Dermatology, Weill Cornell Medicine, New York, New YorkCorrespondence to: Shari R. Lipner, MD, PhD, Department of Dermatology, Weill Cornell Medicine, 1305 York Avenue, New York, NY 10021.; Department of Dermatology, Weill Cornell Medicine, New York, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2352512621006433adverse reactionBeau linesCOVID-19nail psoriasisnailsonycholysis
spellingShingle Jose W. Ricardo, MD
Shari R. Lipner, MD, PhD
Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
JAAD Case Reports
adverse reaction
Beau lines
COVID-19
nail psoriasis
nails
onycholysis
title Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_full Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_fullStr Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_full_unstemmed Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_short Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_sort case of de novo nail psoriasis triggered by the second dose of pfizer biontech bnt162b2 covid 19 messenger rna vaccine
topic adverse reaction
Beau lines
COVID-19
nail psoriasis
nails
onycholysis
url http://www.sciencedirect.com/science/article/pii/S2352512621006433
work_keys_str_mv AT josewricardomd caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine
AT sharirlipnermdphd caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine